List of insiders holdings for Epizyme Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BARRIS PETER J 10% Owner |
2016-01-12 17:32:04 | 0 6,261,599 |
6,261,599 | Form 4 |
| 2 | SANDELL SCOTT D 10% Owner |
2016-01-12 17:34:56 | 0 6,261,502 |
6,261,502 | Form 4 |
| 3 | KERINS PATRICK J 10% Owner |
2016-01-12 17:33:25 | 651 6,260,851 |
6,261,502 | Form 4 |
| 4 | Viswanathan Ravi 10% Owner |
2016-01-12 17:35:26 | 0 6,260,851 |
6,260,851 | Form 4 |
| 5 | BARRETT M JAMES 10% Owner |
2016-01-12 17:31:28 | 0 6,260,851 |
6,260,851 | Form 4 |
| 6 | Weller Harry R 10% Owner |
2016-01-12 17:35:59 | 0 6,260,851 |
6,260,851 | Form 4 |
| 7 | BASKETT FOREST 10% Owner |
2016-01-12 17:32:37 | 0 6,260,851 |
6,260,851 | Form 4 |
| 8 | KOLLURI KRISHNA KITTU 10% Owner |
2016-01-12 17:33:52 | 0 6,260,851 |
6,260,851 | Form 4 |
| 9 | SEIDENBERG BETH C Director |
2019-07-02 16:16:52 | 8,481 4,115,555 |
4,124,036 | Form 4 |
| 10 | KPCB XIII Associates LLC KLEINER PERKINS CAUFIELD & BYERS XIII LLC 10% Owner |
2019-02-14 13:44:52 | 3,838,167 0 |
3,838,167 | Form 13G |
| 11 | Celgene European Investment Co LLC CELGENE CORP 10% Owner |
2020-02-10 17:27:36 | 3,674,640 0 |
3,674,640 | Form 13G |
| 12 | BAY CITY CAPITAL LLC Bay City Capital Fund V Co-Investment Fund L.P. Bay City Capital Fund V L.P. Bay City Capital Management V LLC 10% Owner |
2016-01-12 16:30:17 | 0 3,380,951 |
3,380,951 | Form 4 |
| 13 | EVNIN LUKE GADICKE ANSBERT 10% Owner |
2014-02-11 15:54:38 | 0 2,413,819 |
2,413,819 | Form 4 |
| 14 | MPM BioVentures IV QP LP Scopa James Paul MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. Foley Todd KAILIAN VAUGHN M 10% Owner |
2016-02-09 18:33:53 | 1,729,674 0 |
1,729,674 | Form 13G |
| 15 | MPM BioVentures IV QP LP Scopa James Paul Vander Vort John MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. Foley Todd KAILIAN VAUGHN M 10% Owner |
2016-02-09 18:33:53 | 1,729,674 0 |
1,729,674 | Form 13G |
| 16 | DRANT RYAN D 10% Owner |
2014-08-18 17:46:43 | 455 1,725,906 |
1,726,361 | Form 4 |
| 17 | Gould Robert J Director |
2015-12-31 10:23:03 | 722,035 0 |
722,035 | Form 4 |
| 18 | Astellas Venture Fund I L.P. Astellas Venture Management LLC 10% Owner |
2013-06-06 20:27:19 | 650,253 0 |
650,253 | Form 4 |
| 19 | Zhang Yi 10% Owner |
2013-05-30 19:23:27 | 495,299 0 |
495,299 | Form 3 |
| 20 | Amgen Ventures LLC AMGEN INC 10% Owner |
2013-06-05 16:01:48 | 334,126 0 |
334,126 | Form 4 |
| 21 | Bazemore Robert B President & CEO |
2021-03-29 16:30:13 | 322,626 0 |
322,626 | Form 4 |
| 22 | Rhodes Jason P President, CFO and Treasurer |
2014-09-24 18:15:43 | 287,459 0 |
287,459 | Form 4 |
| 23 | Hedrick Eric Chief Medical Officer |
2014-10-17 18:52:11 | 276,929 0 |
276,929 | Form 4 |
| 24 | Horvitz H Robert 10% Owner |
2013-05-30 19:24:34 | 239,655 24,660 |
264,315 | Form 3 |
| 25 | Ros Matthew See Remarks |
2021-08-18 08:02:56 | 245,491 0 |
245,491 | Form 4 |
| 26 | Graf Susan E Chief Business Officer |
2018-02-13 17:05:56 | 106,344 0 |
106,344 | Form 4 |
| 27 | Singer Andrew E. EVP & CFO |
2017-08-10 15:47:35 | 89,712 0 |
89,712 | Form 4 |
| 28 | Copeland Robert A President of Research and CSO |
2017-06-07 13:48:55 | 67,588 0 |
67,588 | Form 4 |
| 29 | Allen Andrew R Director |
2021-06-15 16:37:03 | 61,119 0 |
61,119 | Form 4 |
| 30 | TOMBESI PAOLO Chief Financial Officer |
2021-02-05 16:40:56 | 53,465 0 |
53,465 | Form 4 |
| 31 | Vakiener Victoria Chief Commercial Officer |
2021-02-05 16:32:30 | 52,685 0 |
52,685 | Form 4 |
| 32 | Garbacz Stephen Principal Accounting Officer |
2014-11-04 18:35:35 | 34,775 0 |
34,775 | Form 4 |
| 33 | Fleming Suzanne SVP |
2018-02-13 17:02:54 | 29,002 0 |
29,002 | Form 4 |
| 34 | Shiosaki Kazumi Director |
2013-06-06 16:48:40 | 17,666 0 |
17,666 | Form 4 |
| 35 | Ho Peter Tai-Ching Chief Development Officer |
2017-10-25 12:29:58 | 13,623 2,000 |
15,623 | Form 4 |
| 36 | POPS RICHARD F Director |
2020-06-02 16:15:55 | 14,013 0 |
14,013 | Form 4 |
| 37 | Giordano Michael F Director |
2022-08-16 19:03:16 | 0 0 |
0 | Form 4 |
| 38 | GOLDFISCHER CARL Director |
2022-08-16 19:02:25 | 0 0 |
0 | Form 4 |
| 39 | Conroy Kevin T Director |
2022-08-16 19:02:02 | 0 0 |
0 | Form 4 |
| 40 | Richon Victoria Director |
2022-08-16 18:59:10 | 0 0 |
0 | Form 4 |
| 41 | MOTT DAVID M Director |
2022-08-16 18:59:01 | 0 0 |
0 | Form 4 |
| 42 | BEVERIDGE ROY A Director |
2022-08-16 18:58:50 | 0 0 |
0 | Form 4 |
| 43 | Agarwal Shefali See Remarks |
2022-08-16 18:57:54 | 0 0 |
0 | Form 4 |
| 44 | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
2022-08-16 18:55:40 | 0 0 |
0 | Form 4 |
| 45 | Beaulieu Joseph See Remarks |
2022-08-16 18:55:17 | 0 0 |
0 | Form 4 |
| 46 | Korn Jerald Chief Operating Officer |
2022-08-16 18:55:41 | 0 0 |
0 | Form 4 |
| 47 | BATE KENNETH Director |
2022-08-16 18:55:00 | 0 0 |
0 | Form 4 |
| 48 | Kutok Jeffery Chief Scientific Officer |
2022-08-16 18:54:59 | 0 0 |
0 | Form 4 |
| 49 | Stuckley Carol Director |
2022-08-16 18:54:41 | 0 0 |
0 | Form 4 |
| 50 | Bogle Grant C. President and CEO |
2022-08-16 18:52:01 | 0 0 |
0 | Form 4 |
| 51 | Daniel Thomas O Director |
2013-05-30 19:25:20 | 0 0 |
0 | Form 3 |
| 52 | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
2019-07-08 16:10:43 | 0 0 |
0 | Form 13D |